10-Q: Pennant Group Reports Strong Q3 Revenue Growth Amidst Regulatory Headwinds

The Pennant Group, Inc. announced significant revenue growth in Q3 2025, driven by acquisitions and improved operational performance in both home health and senior living segments, despite a slight dip in quarterly net income.

Summary

• Total revenue increased by $48.4 million (26.8%) to $229.039 million for the three months ended September 30, 2025, compared to $180.688 million in the prior year.
• Total revenue increased by $152.0 million (30.0%) to $658.382 million for the nine months ended September 30, 2025, compared to $506.348 million in the prior year.
• Net income attributable to The Pennant Group, Inc. decreased slightly to $6.081 million for the three months ended September 30, 2025, from $6.205 million in the prior year.
• Net income attributable to The Pennant Group, Inc. increased to $20.941 million for the nine months ended September 30, 2025, from $16.801 million in the prior year.
• Basic earnings per share decreased to $0.18 for the three months ended September 30, 2025, from $0.20 in the prior year, while diluted EPS decreased to $0.17 from $0.20.
• Basic earnings per share increased to $0.61 for the nine months ended September 30, 2025, from $0.56 in the prior year, while diluted EPS increased to $0.59 from $0.54.
• The company expanded its operations with the addition of nine home health agencies, four hospice agencies, and four senior living communities during the nine months ended September 30, 2025.
• Post-period, on October 1, 2025, the company acquired 21 home health agencies, five hospice agencies, and four home care agencies from UnitedHealth Group Incorporated and Amedisys, Inc. for $146.5 million in cash.
• CMS proposed a -6.4% net payment update for the Calendar Year 2026 Home Health Prospective Payment System, potentially decreasing payments by an estimated $1.135 billion.
• CMS finalized a 2.6% payment update for the 2026 Hospice Wage Index and Payment Rate Update, an estimated increase of $750 million in payments.
• The One Big Beautiful Bill Act (OBBBA), signed July 4, 2025, enacts significant reforms to the Medicaid program that may indirectly impact the company's operations and state budgets.

Sentiment

Score: 5

Explanation: While the company achieved substantial revenue growth through acquisitions and improved some operational metrics, the decline in Q3 net income and EPS, coupled with increasing cost of services and general & administrative expenses, indicates pressure on profitability. Significant proposed Medicare reimbursement cuts for home health and the potential impacts of the OBBBA introduce considerable future uncertainty and risk. The large post-period acquisition and new term loan show continued growth strategy but also increased debt.

Positives

• Total revenue increased by 26.8% for the three months and 30.0% for the nine months ended September 30, 2025, demonstrating strong top-line growth.
• The Home Health and Hospice Services segment revenue grew by 27.9% for the three months and 32.3% for the nine months ended September 30, 2025, driven by increased admissions and census.
• The Senior Living Services segment revenue increased by 23.2% for the three months and 23.3% for the nine months ended September 30, 2025, due to acquired communities and improved average rate per occupied room and occupancy.
• Senior living occupancy improved by 180 basis points to 80.9% for the three months ended September 30, 2025, compared to 79.1% in the prior year.
• Average monthly revenue per occupied unit in senior living increased by 7.4% to $5,195 for the three months ended September 30, 2025.
• Net cash provided by operating activities increased by $8.6 million to $27.336 million for the nine months ended September 30, 2025.
• The company completed significant acquisitions, adding 9 home health, 4 hospice, and 4 senior living communities during the nine months ended September 30, 2025.
• A major post-period acquisition of 30 agencies from UnitedHealth Group and Amedisys for $146.5 million indicates continued strategic expansion.
• The company was compliant with all financial covenants of its Amended Revolving Credit Facility as of September 30, 2025.
• Management believes existing cash, cash from operations, and available credit will provide adequate liquidity for the next twelve months for operations and acquisition growth.

Negatives

• Net income attributable to The Pennant Group, Inc. decreased by 2.0% for the three months ended September 30, 2025, despite significant revenue growth.
• Basic and diluted earnings per share decreased for the three months ended September 30, 2025.
• Cost of services as a percentage of revenue increased by 100 basis points to 81.0% for the three months ended September 30, 2025, and by 70 basis points to 80.8% for the nine months ended September 30, 2025.
• Senior Living Services segment's cost of services as a percentage of revenue increased by 220 basis points for the three months and 180 basis points for the nine months ended September 30, 2025, primarily due to decreases in state relief funding.
• General and administrative expense increased substantially by 48.2% for the three months and 42.4% for the nine months ended September 30, 2025, partly due to acquisition activities.
• Cash balance significantly decreased from $24.246 million at December 31, 2024, to $2.336 million at September 30, 2025.
• Net cash used in investing activities increased by $8.7 million for the nine months ended September 30, 2025, primarily driven by business acquisitions.
• Net cash provided by financing activities decreased by approximately $20.3 million for the nine months ended September 30, 2025.
• CMS proposed a -6.4% net payment update for the CY 2026 Home Health Prospective Payment System, which could result in an aggregate estimated decrease of $1.135 billion in payments for home health providers.
• The effective tax rate increased for both the three and nine months ended September 30, 2025, primarily due to more compensation subject to IRC Section 162(m) and less excess tax benefits on equity compensation.

Risks

• Federal and state changes to, or delays receiving, reimbursement and other aspects of Medicaid and Medicare, including proposed Medicare reimbursement reductions in the Calendar Year 2026 Home Health Prospective Payment System Proposed Rule and changes to Medicaid funding within the One Big Beautiful Bill Act.
• Changes in, and compliance with, the laws and regulations affecting the U.S. healthcare industry.
• Proposed changes to payment models and reimbursement amounts within the Medicare and Medicaid fee schedules for future calendar years.
• Future cost containment measures undertaken by payors.
• Government reviews, audits, and investigations of the business.
• Potential additional regulation affecting the transparency, ownership, operating standards, conditions of licensure or participation in certain payment programs, and staffing of businesses in the industry.
• Increased competition and increased cost of acquisition or retention for, or a shortage of, skilled personnel.
• Achievement and maintenance of competitive quality of care ratings and referrals from referral sources.
• Changes in, and compliance with, state and federal employment, fair housing, safety, licensing, and other laws.
• Competition from other healthcare providers, federal and state efforts to regulate or deregulate the healthcare services industry, including through staffing levels and requirements, or the construction or expansion of the number of home health, hospice, or senior living operations.
• Actions of labor unions, including strikes, work stoppages, unfair labor practices claims, or related labor activity.
• Costs associated with litigation or any future litigation settlements, including professional liability claims, elder abuse, wrongful death, employment-related claims (e.g., wage and hour class actions), and potential lawsuits under the False Claims Act (FCA) and comparable state laws.
• Risks associated with leases of affiliated senior living communities, including master lease arrangements where a breach at a single community could subject other communities covered by the same master lease to default risk.
• Inability to complete future acquisitions at attractive prices or at all, and failure to successfully or efficiently integrate new acquisitions into existing operations and operating subsidiaries.
• General economic conditions, including a housing downturn, which could affect seniors' ability to afford resident fees, or inflation and increasing interest rates, which raise the costs of goods and borrowing capital, potentially affecting the delivery and affordability of services.
• Security breaches and other cybersecurity incidents.
• The performance of the financial and credit markets and uncertainties related to the ability to obtain financing or the terms of such financing.
• Potential adverse effects from the federal government shutdown commencing October 1, 2025, due to prohibited CMS activities and the unknown duration of this shutdown.
• Risk of significant penalties for the knowing retention of government overpayments under the Fraud Enforcement and Recovery Act (FERA).

Future Outlook

Management anticipates that the total goodwill recognized from the Signature Group, LLC acquisition will be fully deductible for tax purposes. The company expects combined metrics to be impacted by turnaround or start-up operations, leading to lower occupancy/census and higher costs at recently acquired senior living communities and home health/hospice agencies, which may result in lower and/or fluctuating consolidated and segment margins during years of acquisition growth. CMS proposed a -6.4% net payment update for the CY 2026 Home Health Prospective Payment System, which could materially impact reimbursement for home health providers, potentially decreasing payments by $1.135 billion. The One Big Beautiful Bill Act (OBBBA) may indirectly impact operations through Medicaid reforms, potentially leading to reduced federal Medicaid funding, changes in eligibility/benefit design, and reductions or delays in reimbursement. The federal government shutdown commencing October 1, 2025, may delay Medicare-funded activities and reviews, potentially affecting operations. The company is currently evaluating the impact of new FASB ASUs on income tax disclosures (ASU 2023-09, effective FY2025), disaggregation of income statement expenses (ASU 2024-03, effective FY2027), and internal-use software accounting (ASU 2025-06, effective FY2028). Management believes existing cash, cash generated through operations, and access to available borrowing capacity under the Amended Credit Agreement will be sufficient for adequate liquidity for the next twelve months for both operating activities and acquisition growth opportunities.

Management Comments

• "We have experienced improvement in senior living revenue per occupied unit and occupancy during the nine months ended September 30, 2025, compared to the same period in 2024."
• "Though we have seen improvements in revenue per occupied unit and occupancy year over year, the highly competitive environment for senior living residents and inflationary factors will continue to impact the rate at which our revenue per occupied unit changes in our senior living communities."
• "When we acquire turnaround or start-up operations, we expect that our combined metrics may be impacted."
• "We expect these metrics to vary from period to period based upon the maturity of the operations within our portfolio."
• "We have generally experienced lower occupancy rates and higher costs at our senior living communities and lower census and higher costs at our home health and hospice agencies for recently acquired operations; as a result, we generally anticipate lower and/or fluctuating consolidated and segment margins during years of acquisition growth."
• "We believe that our existing cash, cash generated through operations, and access to available borrowing capacity under our Amended Credit Agreement, will be sufficient to provide adequate liquidity for the next twelve months for both our operating activities and for opportunities of acquisition growth."

Industry Context

The healthcare industry, particularly post-acute care, is heavily influenced by government regulations and reimbursement policies from Medicare and Medicaid. Proposed changes to the Home Health Prospective Payment System (HH PPS) for CY 2026 indicate potential significant payment reductions, while hospice payments are expected to increase. The One Big Beautiful Bill Act (OBBBA) introduces reforms to Medicaid that could impact state funding and provider reimbursements, requiring states like California to adapt with specific budget allocations. The industry also faces challenges from increased competition, staffing shortages, and inflationary pressures, which impact operational costs and the ability to attract and retain residents/patients. The company's strategy of acquiring turnaround or start-up operations aligns with a growth-by-acquisition trend in fragmented healthcare sectors, but also introduces integration challenges and potential short-term margin fluctuations.

Legal Proceedings

• Involved in various claims and lawsuits arising in the ordinary course of business, including professional liability claims (personal injury, elder abuse, wrongful death), employment-related claims (wage and hour class actions), and potential lawsuits under the False Claims Act (FCA) and comparable state laws.
• Subject to probe reviews relating to Medicare services, billings, and potential overpayments by various contractors (UPIC, RAC, ZPIC, PSC, SMRC, MIC programs). As of September 30, 2025, 13 independent operating subsidiaries had Reviews scheduled, on appeal, or in dispute resolution.

Related Party Transactions

• Certain directors serving on Pennant's Board also serve as directors of The Ensign Group, Inc. (Ensign) and own Ensign common stock.
• Pennant and Ensign continue to partner in the provision of services along the healthcare continuum.
• Incurred costs of $69 thousand for the three months and $472 thousand for the nine months ended September 30, 2025, related primarily to shared services at proximate operations with Ensign.
• Expenses related to room and board charges at Ensign skilled nursing facilities for hospice patients were $1,713 thousand for the three months and $4,921 thousand for the nine months ended September 30, 2025.
• Pennant's independent operating subsidiaries leased 32 communities from subsidiaries of Ensign under master lease arrangements as of September 30, 2025. Total rent expense paid to Ensign subsidiaries was $3,757 thousand for the three months and $11,266 thousand for the nine months ended September 30, 2025.

Stakeholder Impact

• Shareholders face potential for increased value from strategic acquisitions and revenue growth, but also risk from declining Q3 net income/EPS, increased costs, and regulatory uncertainties (Medicare cuts, Medicaid reforms).
• Employees may experience increased demand for skilled personnel due to growth, but also face risks of increased cost of acquisition or retention, and potential impact from labor union actions.
• Customers/Patients/Residents will continue to receive high-quality healthcare services, but potential changes in Medicare/Medicaid reimbursement and cost-containment measures could impact affordability and access to services.
• Suppliers will likely see increased business volume due to the company's expansion and acquisition activities.
• Creditors are impacted by the company's debt structure and compliance with covenants, which are currently met, but the new incremental term loan increases leverage.

Next Steps

• Evaluate the impact of ASU 2023-09 (Income Tax Disclosures) for fiscal year 2025.
• Evaluate the impact of ASU 2024-03 (Disaggregation of Income Statement Expenses) for fiscal year 2027.
• Evaluate the impact of ASU 2025-06 (Internal-Use Software) for fiscal year 2028.
• Present required disclosures for the October 1, 2025, acquisition from UnitedHealth Group and Amedisys in future periods, as initial accounting is incomplete.
• Monitor the finalization of the CY 2026 Home Health Prospective Payment System proposed rule and its impact on reimbursement.
• Monitor state actions to address the One Big Beautiful Bill Act (OBBBA) and its potential effects on Medicaid funding and reimbursement.
• Address potential delays in Medicare-funded activities and reviews due to the federal government shutdown.
• Continue to integrate newly acquired operations and manage associated costs and occupancy rates.

Key Dates

Recommendation

While Pennant Group demonstrates robust top-line growth driven by strategic acquisitions and improved operational metrics in its senior living segment, the recent quarter's decline in net income and EPS, coupled with rising operating costs, signals profitability pressures. The proposed significant Medicare reimbursement cuts for home health services in 2026 and the uncertainties surrounding Medicaid reforms from the OBBBA present material headwinds. The company's aggressive acquisition strategy, while expanding its footprint, also introduces integration risks and can impact short-term margins. The recent $100 million incremental term loan indicates continued investment in growth, but also adds to leverage. Given the mixed financial performance, significant regulatory risks, and ongoing integration challenges, a "Hold" recommendation is appropriate as investors should monitor how the company navigates these pressures and integrates its new assets to translate revenue growth into sustainable earnings.

Keywords

Home Health, Hospice, Senior Living, Healthcare Services, Post-Acute Care, Medicare, Medicaid, Acquisitions, Financial Results, 10-Q, PNTG